InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated vasculitis (AAV) The Company is assessing the most efficient ...

A major new study has found that mental health and behavioural changes such as depression, anxiety, and emotional instability are common in people who survive encephalitis — inflammation of the brain ...